PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 89 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $61,296 | -70.5% | 19,837 | -59.7% | 0.00% | -75.0% |
| Q4 2022 | $208,082 | +383.9% | 49,192 | +169.1% | 0.00% | +300.0% |
| Q3 2022 | $43,000 | -85.5% | 18,283 | -82.5% | 0.00% | -87.5% |
| Q2 2022 | $297,000 | -52.9% | 104,223 | -52.4% | 0.01% | -52.9% |
| Q1 2022 | $630,000 | -48.6% | 218,917 | -45.7% | 0.02% | -55.3% |
| Q4 2021 | $1,225,000 | +402.0% | 403,119 | +1350.1% | 0.04% | +137.5% |
| Q4 2019 | $244,000 | -35.6% | 27,800 | -6.7% | 0.02% | -61.9% |
| Q2 2019 | $379,000 | +205.6% | 29,800 | +1001.3% | 0.04% | -27.6% |
| Q3 2018 | $124,000 | – | 2,706 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $13,338,000 | 2.17% |
| Camber Capital Management LP | 2,555,000 | $26,214,000 | 0.92% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,959,741 | $40,627,000 | 0.80% |
| Palo Alto Investors LP | 1,373,897 | $14,096,000 | 0.74% |
| Sofinnova Investments, Inc. | 629,650 | $6,460,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 604,937 | $6,207,000 | 0.22% |
| J. Goldman & Co LP | 238,617 | $2,448,000 | 0.12% |
| GLOBEFLEX CAPITAL L P | 55,027 | $565,000 | 0.12% |
| FRED ALGER MANAGEMENT, LLC | 3,416,003 | $35,048,000 | 0.09% |
| JUPITER ASSET MANAGEMENT LTD | 728,440 | $7,474,000 | 0.08% |